These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 25973922)

  • 1. A panel of novel biomarkers representing different disease pathways improves prediction of renal function decline in type 2 diabetes.
    Pena MJ; Heinzel A; Heinze G; Alkhalaf A; Bakker SJ; Nguyen TQ; Goldschmeding R; Bilo HJ; Perco P; Mayer B; de Zeeuw D; Lambers Heerspink HJ
    PLoS One; 2015; 10(5):e0120995. PubMed ID: 25973922
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systems Biology-Derived Biomarkers to Predict Progression of Renal Function Decline in Type 2 Diabetes.
    Mayer G; Heerspink HJ; Aschauer C; Heinzel A; Heinze G; Kainz A; Sunzenauer J; Perco P; de Zeeuw D; Rossing P; Pena M; Oberbauer R;
    Diabetes Care; 2017 Mar; 40(3):391-397. PubMed ID: 28077457
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Associations of Plasma Biomarkers of Inflammation, Fibrosis, and Kidney Tubular Injury With Progression of Diabetic Kidney Disease: A Cohort Study.
    Gutiérrez OM; Shlipak MG; Katz R; Waikar SS; Greenberg JH; Schrauben SJ; Coca S; Parikh CR; Vasan RS; Feldman HI; Kimmel PL; Cushman M; Bonventre JV; Sarnak MJ; Ix JH
    Am J Kidney Dis; 2022 Jun; 79(6):849-857.e1. PubMed ID: 34752914
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of Multiple Plasma Biomarker Concentrations with Progression of Prevalent Diabetic Kidney Disease: Findings from the Chronic Renal Insufficiency Cohort (CRIC) Study.
    Schrauben SJ; Shou H; Zhang X; Anderson AH; Bonventre JV; Chen J; Coca S; Furth SL; Greenberg JH; Gutierrez OM; Ix JH; Lash JP; Parikh CR; Rebholz CM; Sabbisetti V; Sarnak MJ; Shlipak MG; Waikar SS; Kimmel PL; Vasan RS; Feldman HI; Schelling JR;
    J Am Soc Nephrol; 2021 Jan; 32(1):115-126. PubMed ID: 33122288
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biomarkers of rapid chronic kidney disease progression in type 2 diabetes.
    Looker HC; Colombo M; Hess S; Brosnan MJ; Farran B; Dalton RN; Wong MC; Turner C; Palmer CN; Nogoceke E; Groop L; Salomaa V; Dunger DB; Agakov F; McKeigue PM; Colhoun HM;
    Kidney Int; 2015 Oct; 88(4):888-96. PubMed ID: 26200946
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Validating the association between plasma tumour necrosis factor receptor 1 levels and the presence of renal injury and functional decline in patients with Type 2 diabetes.
    Doody A; Jackson S; Elliott JA; Canavan RJ; Godson C; Slattery D; Twomey PJ; McKenna MJ; le Roux CW; Docherty NG
    J Diabetes Complications; 2018 Jan; 32(1):95-99. PubMed ID: 29122448
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Markers of early progressive renal decline in type 2 diabetes suggest different implications for etiological studies and prognostic tests development.
    Nowak N; Skupien J; Smiles AM; Yamanouchi M; Niewczas MA; Galecki AT; Duffin KL; Breyer MD; Pullen N; Bonventre JV; Krolewski AS
    Kidney Int; 2018 May; 93(5):1198-1206. PubMed ID: 29398132
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low erythropoietin levels predict faster renal function decline in diabetic patients with anemia: a prospective cohort study.
    Fujita Y; Doi Y; Hamano T; Hatazaki M; Umayahara Y; Isaka Y; Tsubakihara Y
    Sci Rep; 2019 Oct; 9(1):14871. PubMed ID: 31619722
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Validation of Plasma Biomarker Candidates for the Prediction of eGFR Decline in Patients With Type 2 Diabetes.
    Heinzel A; Kammer M; Mayer G; Reindl-Schwaighofer R; Hu K; Perco P; Eder S; Rosivall L; Mark PB; Ju W; Kretzler M; Gilmour P; Wilson JM; Duffin KL; Abdalla M; McCarthy MI; Heinze G; Heerspink HL; Wiecek A; Gomez MF; Oberbauer R;
    Diabetes Care; 2018 Sep; 41(9):1947-1954. PubMed ID: 29980527
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma Leucine-Rich α-2-Glycoprotein 1 Predicts Rapid eGFR Decline and Albuminuria Progression in Type 2 Diabetes Mellitus.
    Liu JJ; Pek SLT; Ang K; Tavintharan S; Lim SC;
    J Clin Endocrinol Metab; 2017 Oct; 102(10):3683-3691. PubMed ID: 28973352
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of Circulating Biomarkers (Adrenomedullin, TNFR1, and NT-proBNP) With Renal Function Decline in Patients With Type 2 Diabetes: A French Prospective Cohort.
    Saulnier PJ; Gand E; Velho G; Mohammedi K; Zaoui P; Fraty M; Halimi JM; Roussel R; Ragot S; Hadjadj S;
    Diabetes Care; 2017 Mar; 40(3):367-374. PubMed ID: 27998909
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical and pathological predictors of estimated GFR decline in patients with type 2 diabetes and overt proteinuric diabetic nephropathy.
    Mise K; Hoshino J; Ueno T; Hazue R; Sumida K; Hiramatsu R; Hasegawa E; Yamanouchi M; Hayami N; Suwabe T; Sawa N; Fujii T; Hara S; Ohashi K; Takaichi K; Ubara Y
    Diabetes Metab Res Rev; 2015 Sep; 31(6):572-81. PubMed ID: 25533683
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of Urinary Biomarkers of Inflammation, Injury, and Fibrosis with Renal Function Decline: The ACCORD Trial.
    Nadkarni GN; Rao V; Ismail-Beigi F; Fonseca VA; Shah SV; Simonson MS; Cantley L; Devarajan P; Parikh CR; Coca SG
    Clin J Am Soc Nephrol; 2016 Aug; 11(8):1343-1352. PubMed ID: 27189318
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk Prediction for Early CKD in Type 2 Diabetes.
    Dunkler D; Gao P; Lee SF; Heinze G; Clase CM; Tobe S; Teo KK; Gerstein H; Mann JF; Oberbauer R;
    Clin J Am Soc Nephrol; 2015 Aug; 10(8):1371-9. PubMed ID: 26175542
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of Novel Circulating Biomarkers Predicting Rapid Decline in Renal Function in Type 2 Diabetes: The Fremantle Diabetes Study Phase II.
    Peters KE; Davis WA; Ito J; Winfield K; Stoll T; Bringans SD; Lipscombe RJ; Davis TME
    Diabetes Care; 2017 Nov; 40(11):1548-1555. PubMed ID: 28851702
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decreased plasma α-Klotho predict progression of nephropathy with type 2 diabetic patients.
    Kim SS; Song SH; Kim IJ; Lee EY; Lee SM; Chung CH; Kwak IS; Lee EK; Kim YK
    J Diabetes Complications; 2016 Jul; 30(5):887-92. PubMed ID: 27037042
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Validation of a protein biomarker test for predicting renal decline in type 2 diabetes: The Fremantle Diabetes Study Phase II.
    Peters KE; Davis WA; Ito J; Bringans SD; Lipscombe RJ; Davis TME
    J Diabetes Complications; 2019 Dec; 33(12):107406. PubMed ID: 31669066
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum kidney injury molecule 1 and β
    Colombo M; Looker HC; Farran B; Hess S; Groop L; Palmer CNA; Brosnan MJ; Dalton RN; Wong M; Turner C; Ahlqvist E; Dunger D; Agakov F; Durrington P; Livingstone S; Betteridge J; McKeigue PM; Colhoun HM;
    Diabetologia; 2019 Jan; 62(1):156-168. PubMed ID: 30288572
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolomic Markers of Kidney Function Decline in Patients With Diabetes: Evidence From the Chronic Renal Insufficiency Cohort (CRIC) Study.
    Kwan B; Fuhrer T; Zhang J; Darshi M; Van Espen B; Montemayor D; de Boer IH; Dobre M; Hsu CY; Kelly TN; Raj DS; Rao PS; Saraf SL; Scialla J; Waikar SS; Sharma K; Natarajan L;
    Am J Kidney Dis; 2020 Oct; 76(4):511-520. PubMed ID: 32387023
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma Biomarkers of Tubular Injury and Inflammation Are Associated with CKD Progression in Children.
    Greenberg JH; Abraham AG; Xu Y; Schelling JR; Feldman HI; Sabbisetti VS; Gonzalez MC; Coca S; Schrauben SJ; Waikar SS; Ramachandran VS; Shlipak MG; Warady B; Kimmel PL; Bonventre JV; Denburg M; Parikh CR; Furth S;
    J Am Soc Nephrol; 2020 May; 31(5):1067-1077. PubMed ID: 32234829
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.